DS Healthcare Group Expands its Distribution Channels in $43 Billion Brazilian Beauty Market

DS Healthcare Group Expands its Distribution Channels in $43 Billion Brazilian
Beauty Market

Products on the shelves of two retail pharmacy chains with 85 locations

Pompano Beach, Aug. 5, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc.
(NASDAQ:DSKX), a leading developer of personal care products, today announced
it has expanded the distribution of its product lines into Brazil's CSB
Drogaria which operates two retail pharmacy chains, Drogasmil and Farmalife,
which together have 85 retail store locations. The stores are primarily
located in the Rio de Janeiro metropolitan area. CSB Drogaria is owned by
Profarma, a leader in the distribution to pharmacies, distributing 18 million
units per month, through 31,000 sales outlets, covering 93% of the consumer
market for pharmaceutical products in Brazil.

DS Healthcare Group is expected to experience rapid sales increases in Brazil,
as its established distribution there grows.

"Our 10 best-selling SKUs which are approved for commercialization and
distribution are currently being sold in the Brazilian market. This includes
our leading hair loss products. We plan on receiving further regulatory
approvals as sales begin to accelerate. We are working with a fantastic
partner there and are excited about this new relationship. Based on the
success of this pilot program, we expect to continue to expand throughout
Profarma's network, one of the biggest distributors in Brazil. We believe our
products have a considerable advantage to anything currently being sold in
Brazil," stated DS Healthcare President and CEO Daniel Khesin.

According to Euromonitor, a market research firm, the Brazilian beauty
industry generated $43 billion in sales in 2011, an increase of 19% over the
prior year.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development and distribution of topical
therapies for personal care, including what management believes is the world's
most effective topical treatment for hair loss. Its products are sold through
a network of salons, online retailers, specialty retailers and selected
department stores. Its brands include DS Laboratories
(www.DSLaboratories.com), Sigma Skin (www.(www.SigmaSkin.com), Polaris
Research Laboratories (www.PolarisReserachLabs.com), The Pure Guild
(www.ThePureGuild.com) and Nutra Origin (www.NutraOrigin.com)

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press
release are forward-looking and made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or strategies, and
are generally preceded by words such as "future," "plan" or "planned,"
"expects," or "projected." These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many of which
are beyond the company's control that may cause actual results to differ
materially from stated expectations. These risk factors include, among others,
limited operating history, difficulty in developing and marketing products,
intense competition, and additional risks factors as discussed in reports
filed by the company with the Securities and Exchange Commission, which are
available at www.sec.gov.

CONTACT: Contact:
         Laurel Moody
         Corporate Profile
Press spacebar to pause and continue. Press esc to stop.